Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations on the basis of available evidence
As summarized in the first article in this continuing medical education series, the currently availa...
Psoriasis is a chronic inflammatory skin disease affecting 2–3% of worldwide population.The extent o...
BACKGROUND Psoriatic arthritis (PsA) and co-morbidities of psoriasis represent a significant clin...
Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US populatio...
Psoriasis is a chronic, inflammatory, multisystem disease which affects up to 3.2% of the U.S popula...
Psoriasis is a chronic inflammatory disease involving multiple organ systems and affecting approxima...
Psoriasis is a chronic inflammatory skin disease that affects over 100 million people worldwide.1 It...
Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children,...
AbstractPsoriasis is a chronic, noncontiguous, inflammatory, multisystem disease with predominantly ...
Background: The association between psoriasis and some diseases has become relevant in recent years....
Psoriasis is a genetically determined, systemic immune-mediated chronic inflammatory disease that ...
This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed fo...
Psoriasis is a genetically determined, systemic immune-mediated chronic inflammatory disease that af...
Psoriasis is a common inflammatory skin condition, often associated with other diseases. Around 25 %...
Objective. To develop an evidence- based guideline for the pharmacologic and nonpharmacologic treatm...
As summarized in the first article in this continuing medical education series, the currently availa...
Psoriasis is a chronic inflammatory skin disease affecting 2–3% of worldwide population.The extent o...
BACKGROUND Psoriatic arthritis (PsA) and co-morbidities of psoriasis represent a significant clin...
Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US populatio...
Psoriasis is a chronic, inflammatory, multisystem disease which affects up to 3.2% of the U.S popula...
Psoriasis is a chronic inflammatory disease involving multiple organ systems and affecting approxima...
Psoriasis is a chronic inflammatory skin disease that affects over 100 million people worldwide.1 It...
Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children,...
AbstractPsoriasis is a chronic, noncontiguous, inflammatory, multisystem disease with predominantly ...
Background: The association between psoriasis and some diseases has become relevant in recent years....
Psoriasis is a genetically determined, systemic immune-mediated chronic inflammatory disease that ...
This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed fo...
Psoriasis is a genetically determined, systemic immune-mediated chronic inflammatory disease that af...
Psoriasis is a common inflammatory skin condition, often associated with other diseases. Around 25 %...
Objective. To develop an evidence- based guideline for the pharmacologic and nonpharmacologic treatm...
As summarized in the first article in this continuing medical education series, the currently availa...
Psoriasis is a chronic inflammatory skin disease affecting 2–3% of worldwide population.The extent o...
BACKGROUND Psoriatic arthritis (PsA) and co-morbidities of psoriasis represent a significant clin...